John G. Bennetts

Mooroolbark Investments Pty Ltd (M-Group) is the venture capital arm of Mooroolbark Group founded in 1997. The firm is headquartered in Victoria, Australia.

Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia.

Glutagen Pty Ltd. develops enzyme therapies for the treatment of gluten intolerance and coeliac disease. The company has two products Glutazyme and Glutaren. The company was founded by Teodor Stelmasiak in 2001 and is headquartered in South Melbourne, Australia.

Datacraft Ltd. provides network integration services and solutions. It specializes in networking, security, operating environments, storage, and contact centre technologies. The firm is a subsidiary of Dimension Data Plc. The company is headquartered in Mooroolbark, Australia.